TME PHARMA
LIVE

Serial Number

79360076

Owner

TME PHARMA AG

Attorney

Ursula B. Day

Filing Date

Nov 3, 2022

Add to watchlist:

No watchlists yet
View on USPTO

TME PHARMA Trademark

Serial Number: 79360076 • Registration: 7423863

TME PHARMA is a trademark filed by TME PHARMA AG on November 3, 2022. The trademark is classified under Class 1 (Chemicals), Class 5 (Pharmaceuticals), Class 42 (Computer & Scientific), Class 44 (Medical Services). The application is currently registered and active.

Owner Contact Info

TME PHARMA AG (3 trademarks)

BERLIN 10589 , DE

Entity Type: 11

Trademark Details

Filing Date

November 3, 2022

Registration Date

June 25, 2024

Published for Opposition

April 9, 2024

Goods & Services

Medicines, medical preparations and medicines for animals, namely, for treating cancer and ophthalmological indications, diagnostic agents for pharmaceutical use; pharmaceuticals and natural remedies, namely, for treating cancer and ophthalmological indications; pharmaceutical compositions, namely, for treating cancer and ophthalmological indications; pharmaceutical preparations, namely, for treating cancer and ophthalmological indications;

Chemicals for use in industry and science, in particular compounds of nucleic acids and derivatives thereof and l-nucleotides and proteins and peptides and derivatives thereof, all for use in the production and development of pharmaceuticals, veterinary and biotechnological products;

Medical services in the field of medicine; medical and clinical examinations; pharmaceutical advice;

Science and technology services, namely, scientific analysis in the field of biotechnology, therapeutics and research and planning services relating to development of pharmaceuticals; medical and pharmacological research services; pharmaceutical research; computer software design; design of databases, design of online databases; computer programming, namely, updating, design and rental of computer software for managing medical patient data, medical teaching and interactive medical simulations; providing online, non-downloadable computer programs and data networks for managing medical patient data, medical teaching and interactive medical simulations; scientific and technological services, namely, scientific analysis in the field of biotechnology, therapeutics and research and design relating thereto in the field of genetic engineering; scientific research for medical purposes and for biochemical use, scientific contract research; research and development of processes, syntheses and devices for the medical sector and research in the fields of chemistry, biology, biophysics, medicine, biochemistry, genetics, genetic engineering, bacteriology; scientific experiments and analyses; surveying; chemistry services, namely, laboratory research in the field of chemistry, biotechnology, medicine; chemical laboratories; medical laboratory services

Filing History

FINAL DECISION TRANSACTION PROCESSED BY IB
Jan 5, 2025 FINO
FINAL DISPOSITION NOTICE SENT TO IB
Dec 12, 2024 FICS
FINAL DISPOSITION PROCESSED
Dec 11, 2024 FIMP
FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
Sep 25, 2024 FICR
NOTICE OF REGISTRATION CONFIRMATION EMAILED
Jun 25, 2024 NRCC
REGISTERED-PRINCIPAL REGISTER
Jun 25, 2024 R.PR
NOTIFICATION OF POSSIBLE OPPOSITION CREATED, TO BE SENT TO IB
Jun 10, 2024 OPNR
NOTIFICATION PROCESSED BY IB
Apr 15, 2024 GPNX
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Apr 9, 2024 NPUB
PUBLISHED FOR OPPOSITION
Apr 9, 2024 PUBO
NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
Mar 27, 2024 OPNS
NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB
Mar 27, 2024 OP2R
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Mar 20, 2024 NONP
APPROVED FOR PUB - PRINCIPAL REGISTER
Feb 29, 2024 CNSA
EXAMINER'S AMENDMENT ENTERED
Feb 29, 2024 XAEC
NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
Feb 29, 2024 GNEN
EXAMINERS AMENDMENT E-MAILED
Feb 29, 2024 GNEA
EXAMINERS AMENDMENT -WRITTEN
Feb 29, 2024 CNEA
TEAS/EMAIL CORRESPONDENCE ENTERED
Feb 28, 2024 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Feb 28, 2024 CRFA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Feb 28, 2024 TROA
REFUSAL PROCESSED BY IB
Oct 11, 2023 RFNP
NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
Sep 14, 2023 RFCS
REFUSAL PROCESSED BY MPU
Sep 13, 2023 RFRR
NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
Aug 23, 2023 RFCR
NON-FINAL ACTION WRITTEN
Aug 22, 2023 CNRT
ASSIGNED TO EXAMINER
Aug 18, 2023 DOCK
APPLICATION FILING RECEIPT MAILED
Jan 17, 2023 MAFR
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Jan 13, 2023 NWOS
SN ASSIGNED FOR SECT 66A APPL FROM IB
Jan 12, 2023 REPR